Prospective study for establishing minimal clinically important differences in patients with surgery for lower extremity metastases

References

• Cleeland CS, O'Mara A, Zagari M, et al. Integrating pain metrics into oncology clinical trials. Clin Cancer Res. 2011;17(21):6646–6650.
   PubMed Web of Science ®Google Scholar
• Schwab JH. CORR Insights®: early improvement in pain and functional outcome but not quality of life after surgery for metastatic long bone disease. Clin Orthop Relat Res. 2018;476(3):546–547.
   PubMed Web of Science ®Google Scholar
• Janssen SJ, Teunis T, Hornicek FJ, et al. Outcome after fixation of metastatic proximal femoral fractures: a systematic review of 40 studies. J Surg Oncol. 2016;114(4):507–519.
   PubMed Web of Science ®Google Scholar
• Sedaghat AR. Understanding the minimal clinically important difference (MCID) of patient-reported outcome measures. Otolaryngol Head Neck Surg. 2019;161(4):551–560.
   PubMed Web of Science ®Google Scholar
• Bedard G, Zeng L, Lam H, et al. Meaningful change in oncology quality-of-life instruments: a systematic literature review. Expert Rev Pharmacoecon Outcomes Res. 2012;12(4):475–483.
   PubMed Web of Science ®Google Scholar
• Copay AG, Eyberg B, Chung AS, et al. Minimum clinically important difference: current trends in the orthopaedic literature, Part II: lower extremity: a systematic review. JBJS Rev. 2018;6(9):e2.
   PubMed Web of Science ®Google Scholar
• Janssen SJ, Paulino Pereira NR, Raskin KA, et al. A comparison of questionnaires for assessing physical function in patients with lower extremity bone metastases. J Surg Oncol. 2016;114(6):691–696.
   PubMed Web of Science ®Google Scholar
• Cella D, Yount S, Rothrock N, et al. The patient-reported outcomes measurement information system (PROMIS): progress of an NIH roadmap cooperative group during its first two years. Med Care. 2007;45(5 Suppl 1):S3–S11.
   Web of Science ®Google Scholar
• Nathan SS, Healey JH, Mellano D, et al. Survival in patients operated on for pathologic fracture: Implications for end-of-life orthopedic care. J Clin Oncol. 2005;23(25):6072–6082.
   PubMed Web of Science ®Google Scholar
• Rose M, Bjorner JB, Gandek B, et al. The PROMIS Physical Function item bank was calibrated to a standardized metric and shown to improve measurement efficiency. J Clin Epidemiol. 2014;67(5):516–526.
   PubMed Web of Science ®Google Scholar
• Oken M, Creech R, Tormey D, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–655.
   PubMed Web of Science ®Google Scholar
• Katagiri H, Okada R, Takagi T, et al. New prognostic factors and scoring system for patients with skeletal metastasis. Cancer Med. 2014;3(5):1359–1367.
   PubMed Web of Science ®Google Scholar
• Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682.
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381.
   PubMed Web of Science ®Google Scholar
• Yost KJ, Eton DT, Garcia SF, et al. Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. J Clin Epidemiol. 2011;64(5):507–516.
   PubMed Web of Science ®Google Scholar
• de Vet HCW, Terluin B, Knol DL, et al. Three ways to quantify uncertainty in individually applied “minimally important change” values. J Clin Epidemiol. 2010;63(1):37–45.
   PubMed Web of Science ®Google Scholar
• Beckerman H, Roebroeck ME, Lankhorst GJ, et al. Smallest real difference, a link between reproducibility and responsiveness. Qual Life Res. 2001;10(7):571–578.
   PubMed Web of Science ®Google Scholar
• Hays RD, Woolley JM. The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics. 2000;18(5):419–423.
   PubMed Web of Science ®Google Scholar
• Thio QCBS, Karhade AV, Ogink PT, et al. Development and internal validation of machine learning algorithms for preoperative survival prediction of extremity metastatic disease. Clin Orthop Relat Res. 2020;478(2):322–333.
   PubMed Web of Science ®Google Scholar
• Engelmann D, Scheffold K, Friedrich M, et al. Death-related anxiety in patients with advanced cancer: validation of the german version of the death and dying distress scale. J Pain Symptom Manage. 2016;52(4):582–587.
   PubMed Web of Science ®Google Scholar
• Yost KJ, Sorensen MV, Hahn EA, et al. Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the functional assessment of cancer therapy-biologic response modifiers (FACT-BRM) instrument. Value Health. 2005;8(2):117–127.
   PubMed Web of Science ®Google Scholar
• Dea N, Versteeg AL, Sahgal A, et al. Metastatic spine disease: should patients with short life expectancy be denied surgical care? An international retrospective cohort study. Neurosurgery. 2020;87(2):303–311.
   PubMed Web of Science ®Google Scholar
• Poghosyan H, Sheldon LK, Leveille SG, et al. Health-related quality of life after surgical treatment in patients with non-small cell lung cancer: a systematic review. Lung Cancer. 2013;81(1):11–26.
   PubMed Web of Science ®Google Scholar
• Karhade AV, Thio QCBS, Ogink PT, et al. Predicting 90-day and 1-year mortality in spinal metastatic disease: development and internal validation. Neurosurgery. 2019;85(4):E671–E681.
   PubMed Web of Science ®Google Scholar
• Zuckerman SL, Chotai S, Devin CJ, et al. Surgical resection of intradural extramedullary spinal tumors: patient reported outcomes and minimum clinically important difference. Spine (Phila Pa 1976)). 2016;41(24):1925–1932.
   PubMed Web of Science ®Google Scholar
• Wong E, Zhang L, Kerba M, et al. Minimal clinically important differences in the EORTC QLQ-BN20 in patients with brain metastases. Support Care Cancer. 2015;23(9):2731–2737.
   PubMed Web of Science ®Google Scholar
• Kc F. Prophylactic internal fixation of metastatic osseous lesions. Cancer. 1960;13:75–76.
   PubMed Web of Science ®Google Scholar
• Harrington KD. New trends in the management of lower extremity metastases. Clin Orthop Relat Res. 1982;(169):53–61.
   Google Scholar
• Sørensen MS, Horstmann PF, Hindsø K, et al. Use of endoprostheses for proximal femur metastases results in a rapid rehabilitation and low risk of implant failure. A prospective population-based study. J Bone Oncol. 2019;19:100264.
   PubMed Web of Science ®Google Scholar
• Hägg O, Fritzell P, Nordwall A, Swedish Lumbar Spine Study Group. The clinical importance of changes in outcome scores after treatment for chronic low back pain. Eur Spine J. 2003;12(1):12–20.
   PubMed Web of Science ®Google Scholar
• Van Der Roer N, Ostelo RWJG, Bekkering GE, et al. Minimal clinically important change for pain intensity, functional status, and general health status in patients with nonspecific low back pain. Spine (Phila Pa 1976). 2006;31:578–582.
   PubMed Web of Science ®Google Scholar
• Sorensen AA, Howard D, Tan WH, et al. Minimal clinically important differences of 3 patient-rated outcomes instruments. J Hand Surg Am. 2013;38(4):641–649.
   PubMed Web of Science ®Google Scholar
• Terwee CB, Roorda LD, Dekker J, et al. Mind the MIC: large variation among populations and methods. J Clin Epidemiol. 2010;63(5):524–534.
   PubMed Web of Science ®Google Scholar
• Janssen SJ. What are the minimum clinically important differences in SF-36 scores in patients with orthopaedic oncologic conditions? Clin Orthop Relat Res. 2020;478(9):2159–2160.
   PubMed Web of Science ®Google Scholar